An aldose reductase inhibitor reverses early diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  2002-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1096/fj.01-0603fjePMID 11709499
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.

  2001cited by this paper
• Effects of 15-month aldose reductase inhibition with fidarestat on the experimental diabetic neuropathy in rats.

  2000cited by this paper
• High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

  2000cited by this paper
• Evaluation of α1‐adrenoceptor antagonist on diabetes‐induced changes in peripheral nerve function, metabolism, and antioxidative defense

  2000cited by this paper
• Aldose reductase-deficient mice are protected from reduction of nerve conduction associated with diabetes

  2000cited by this paper
• Alpha‐Lipoic Acid Effects And Combination Therapy With Gamma‐Linolenic Acid

  2000cited by this paper
• Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study

  2000cited by this paper
• Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy.

  2000cited by this paper
• The missing link: a single unifying mechanism for diabetic complications.

  2000cited by this paper
• Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.

  2000cited by this paper
• A protein kinase C-beta-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats.

  1999influential reference
• Nerve conduction impairment in experimental diabetes—proximodistal gradient of severity

  1999cited by this paper
• Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.

  1999cited by this paper
• Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.

  1999cited by this paper
• Experimental diabetic neuropathy: an update

  1999cited by this paper
• Diabetic neuropathy: pathogenesis and therapy.

  1999cited by this paper
• Continuous inhibition of excessive polyol pathway flux in peripheral nerves by aldose reductase inhibitor fidarestat leads to improvement of diabetic neuropathy.

  1999cited by this paper
• Modelling cortical cataractogenesis 22: is in vitro reduction of damage in model diabetic rat cataract by taurine due to its antioxidant activity?

  1999cited by this paper
• High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats.

  1999cited by this paper
• Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy

  1999cited by this paper
• Contributions of polyol pathway to oxidative stress in diabetic cataract

  1999cited by this paper
• Aldose reductase inhibitors: therapeutic implications for diabetic complications.

  1999cited by this paper
• Protein kinase C effects on nerve function, perfusion, Na+,K+-ATPase activity and glutathione content in diabetic rats

  1999cited by this paper
• Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

  1999influential reference
• Mitogen-activated protein kinases as glucose transducers for diabetic complications

  1999cited by this paper
• An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells.

  1998cited by this paper
• An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-β and protein kinase C activity in cultured human mesangial cells

  1998cited by this paper
• Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.

  1998cited by this paper
• Reactions of N-methyl-2-phenylindole with malondialdehyde and 4-hydroxyalkenals. Mechanistic aspects of the colorimetric assay of lipid peroxidation.

  1998cited by this paper
• Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid

  1998cited by this paper
• Depletion of Phospholipid Arachidonoyl‐Containing Molecular Species in a Human Schwann Cell Line Grown in Elevated Glucose and Their Restoration by an Aldose Reductase Inhibitor

  1998cited by this paper
• Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase

  1998influential reference
• Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene

  1998cited by this paper
• Nerve conduction velocity, laser Doppler flow, and axonal caliber in galactose and streptozotocin diabetes.

  1998cited by this paper
• Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis/secretion of nerve growth factor.

  1998cited by this paper
• Effects of the peptide HP228 on nerve disorders in diabetic rats.

  1998cited by this paper
• Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.

  1998cited by this paper
• Anti-ulcer effects of antioxidants: effect of probucol.

  1998cited by this paper
• A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy

  1998cited by this paper
• Effects of a novel potent aldose reductase inhibitor, GP-1447, on aldose reductase activity in vitro and on diabetic neuropathy and cataract formation in rats.

  1997cited by this paper
• Aldose Reductase Inhibition Increases CNTF-Like Bioactivity and Protein in Sciatic Nerves From Galactose-Fed and Normal Rats

  1997cited by this paper
• Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats

  1997cited by this paper
• Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

  1997influential reference
• Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus

  1997cited by this paper
• Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy

  1997cited by this paper
• The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy?

  1997cited by this paper
• Aminoguanidine‐effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin‐diabetic rats

  1997cited by this paper
• Aldose Reductase Inhibitors: The End of an Era or the Need for Different Trial Designs?

  1997cited by this paper
• Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.

  1997cited by this paper
• Effects of the sulphydryl donor N‐acetyl‐L‐cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats

  1996cited by this paper
• Galactosemic Neuropathy in Transgenic Mice for Human Aldose Reductase

  1996cited by this paper
• Effects of Beraprost Sodium and Insulin on the Electroretinogram, Nerve Conduction, and Nerve Blood Flow in Rats with Streptozotocin-Induced Diabetes

  1996cited by this paper
• Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor.

  1996cited by this paper
• BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells.

  1996cited by this paper
• Reversal of defective peripheral nerve conduction velocity, nutritive endoneurial blood flow, and oxygenation by a novel aldose reductase inhibitor, WAY-121,509, in streptozotocin-induced diabetic rats.

  1996cited by this paper
• Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine

  1996cited by this paper
• An aldose reductase inhibitor but not myo-inositol blocks enhanced polyphosphoinositide turnover in peripheral nerve from diabetic rats.

  1996cited by this paper
• Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition.

  1996cited by this paper
• Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids

  1995cited by this paper
• The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

  1995cited by this paper
• Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic Neuropathy

  1995influential reference
• alpha-Lipoic acid as a biological antioxidant.

  1995cited by this paper
• Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.

  1995influential reference
• Free Radicals Generated during the Glycation Reaction of Amino Acids by Methylglyoxal

  1995cited by this paper
• Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: Dose-response considerations and independence from a myo-inositol mechanism

  1994influential reference
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve.

  1994cited by this paper
• Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.

  1994cited by this paper
• Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy.

  1994cited by this paper
• Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats

  1994cited by this paper
• Effect of external cation concentration and metabolic inhibitors on membrane potential of human glial cells.

  1993cited by this paper
• Hyperglycemic Pseudohypoxia and Diabetic Complications

  1993cited by this paper
• Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat

  1993cited by this paper
• Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.

  1992cited by this paper
• Muscle and nerve dysfunction in rats with experimental galactosaemia

  1992cited by this paper
• Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition.

  1992cited by this paper
• Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat

  1992cited by this paper
• Perineurial Window: Demyelination in Nonherniated Endoneurium with Reduced Nerve Blood Flow

  1992cited by this paper
• Adenosine Triphosphatase Activity in Sciatic Nerve Tissue of Streptozocin-Induced Diabetic Rats with and without High Dietary Sucrose: Effect of Aldose Reductase Inhibitors

  1991cited by this paper
• Effect of ischemia and reperfusion in vivo on energy metabolism of rat sciatic-tibial and caudal nerves.

  1991cited by this paper
• Diminished Specific Activity of Cytosolic Protein Kinase C In Sciatic Nerve of Streptozocin-Induced Diabetic Rats and Its Correction by Dietary myo-Inositol

  1991cited by this paper
• Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.

  1991cited by this paper
• The Gibbs-Donnan near-equilibrium system of heart.

  1990cited by this paper
• Diabetic Autonomic Neuropathy in BB Rats and Effect of ARI Treatment on Heart-Rate Variability and Vagus Nerve Structure

  1990cited by this paper
• Effects of Aldose Reductase Inhibitor Sorbinil on Neuroaxonal Dystrophy and Levels of myo-inositol and Sorbitol in Sympathetic Autonomic Ganglia of Streptozocin-Induced Diabetic Rats

  1989cited by this paper
• Effects of long-term streptozotocin diabetes on the contractile and histochemical properties of rat muscles.

  1989cited by this paper
• Effect of Prostaglandin E1 Analogue TFC 612 on Diabetic Neuropathy in Streptozocin-Induced Diabetic Rats Comparison With Aldose Reductase Inhibitor ONO 2235

  1989cited by this paper
• Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves.

  1988cited by this paper
• The effects of Sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat

  1986cited by this paper
• Relationship between nerve blood flow and intercapillary distance in peripheral nerve edema.

  1986cited by this paper
• Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy.

  1985cited by this paper
• Prevention and Reversal of Defective Axonal Transport and Motor Nerve Conduction Velocity In Rats with Experimental Diabetes by Treatment with the Aldose Reductase Inhibitor Sorbinil

  1984cited by this paper
• Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.

  1984cited by this paper
• Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus.

  1982cited by this paper
• Potential clamp analysis of the effect of anoxia on the nodal function of rat peripheral nerve fibres.

  1981cited by this paper
• [Clinical biochemistry].

  1980cited by this paper
• A fluorometric method for determination of oxidized and reduced glutathione in tissues.

  1976cited by this paper
• Vitamin C.

  1971cited by this paper
• The redox state of free nicotinamide-adenine dinucleotide phosphate in the cytoplasm of rat liver.

  1969cited by this paper
• The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver.

  1967cited by this paper

• A Protective Role of Hydrogen Sulfide Donor GYY4137 Through Activated Microglia-induced Anti-inflammatory Cytokines in the Spinal Cord of Diabetic Rats

  2026cites this paper
• Hyperglycemia-induced mitochondrial abnormalities in autonomic neurons via the RAGE axis

  2025cites this paper
• Oxidative stress in diabetes mellitus and its complications: From pathophysiology to therapeutic strategies

  2024cites this paper
• Exploring aldose reductase inhibitors as promising therapeutic targets for diabetes-linked disabilities.

  2024cites this paper
• SORDD: mutation frequency and phenotype in predominantly axonal Charcot-Marie-Tooth disease of undefined genetic cause

  2024cites this paper
• Remodeling of the Intracardiac Ganglia During the Development of Cardiovascular Autonomic Dysfunction in Type 2 Diabetes: Molecular Mechanisms and Therapeutics

  2024cites this paper
• Non-invasive blood sugar detection by cost-effective capacitance spectroscopy

  2023cites this paper
• The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications

  2023cites this paper
• Discovery of a novel benzothiadiazine-based selective aldose reductase inhibitor as potential therapy for diabetic peripheral neuropathy.

  2023cites this paper
• Role of oxidative stress in diabetes-induced complications and their management with antioxidants

  2023cites this paper
• Axonal transport deficits in the pathogenesis of diabetic peripheral neuropathy

  2023cites this paper
• The ocular surface and diabetes, the other 21st Century epidemic.

  2022cites this paper
• Oxidative Stress and Mitochondrial Dysfunction Associated with Peripheral Neuropathy in Type 1 Diabetes

  2021cites this paper
• Sorbitol accumulation decreases oocyte quality in aged mice by altering the intracellular redox balance

  2021cites this paper
• Sensory neurons derived from diabetic rats exhibit deficits in functional glycolysis and ATP that are ameliorated by IGF-1

  2021cites this paper
• Exercise and Nutraceuticals: Eminent approach for Diabetic Neuropathy.

  2021cites this paper
• A Mixed Comparisons of Different Intensities and Types of Physical Exercise in Patients With Diseases Related to Oxidative Stress: A Systematic Review and Network Meta-Analysis

  2021cites this paper
• Effect of Cyperus squarrosus plant extracts on diabetic neuropathy in Streptozotocin (STZ)–induced diabetic rats

  2021cites this paper
• Pathophysiology

  2020cites this paper
• Diabetic Foot – Research

  2020cites this paper
• Pathogenesis

  2020cites this paper
• Effect of Vanillic Acid on Nerve Conduction Velocity in Chronic Constriction Injury Model of Neuropathy

  2019cites this paper
• Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences

  2019cites this paper
• Sarm1 Gene Deficiency Attenuates Diabetic Peripheral Neuropathy in Mice

  2019cites this paper
• Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.

  2019cites this paper
• Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials

  2018cites this paper
• Synergistic potential of Zingiber officinale and Curcuma longa to ameliorate diabetic-dyslipidemia.

  2018cites this paper
• Potential therapeutic role of melatonin on STZ-induced diabetic central neuropathy: A biochemical, histopathological, immunohistochemical and ultrastructural study.

  2018cites this paper
• Comparison of the Effects of Prophylactic and Therapeutic Administrations on Peripheral Neuropathy in Streptozotocin-Diabetic Rats with Gliclazide or Methylcobalamin

  2018cites this paper
• Glycosylated Hemoglobin and Its Relation with Lipid Peroxidation in Type-2 Diabetes Mellitus

  2018cites this paper
• Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets

  2018cites this paper
• Role of phytotherapy in diabetic neuropathy and neurodegeneration: from pathogenesis to treatment

  2018cites this paper
• Inhibitory effect of effective fraction of Salvia officinalis on aldose reductase activity: strategy to reduce complications of type 2 diabetes

  2018influential citation
• Inhibition of miR-25 aggravates diabetic peripheral neuropathy

  2018cites this paper
• 10.Bibliography

  2018cites this paper
• Marine Sea Cucumber Saponins and Diabetes

  2017cites this paper
• Oxidative Stress and Nutrition

  2017cites this paper
• Fluctuations in glucose levels induce glial toxicity with glutamatergic, oxidative and inflammatory implications.

  2017cites this paper
• Antioxidant Effects of the Quercetin in the Jejunal Myenteric Innervation of Diabetic Rats

  2017cites this paper
• Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!

  2017cites this paper
• Antioxidant Effects of Biochanin A in Streptozotocin Induced Diabetic Rats

  2017cites this paper
• The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis

  2017cites this paper
• Protein extract from the fruit pulp of Momordica dioica shows anti-diabetic, anti-lipidemic and antioxidant activity in diabetic rats

  2017cites this paper
• Comparative Study of Malondialdehyde and Vitamin C in Type 2 Diabetes Mellitus and Non Diabetic Individuals

  2016cites this paper
• Diabolical effects of rabies encephalitis

  2016cites this paper
• Utilidad del test de la función sudomotora como instrumento clínico de clasificación de riesgo del paciente diabético

  2016cites this paper
• Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract

  2016cites this paper
• Correlation between Oxidative Stress Markers and Atherogenic Indices in Type 2 Diabetes Mellitus

  2016cites this paper
• Impact of antioxidants on seminal vesicles function and fertilizing potential in diabetic rats

  2016cites this paper
• Optimized donor management and organ preservation before kidney transplantation

  2016cites this paper
• Desired and side effects of the supplementation with l-glutamine and l-glutathione in enteric glia of diabetic rats.

  2016cites this paper
• Selection Strategy of In Vivo Models for Ophthalmic Drug Development in Diabetic Retinopathy

  2016cites this paper
• Aldose Reductase as a Drug Target for Treatment of Diabetic Nephropathy: Promises and Challenges.

  2016cites this paper
• Antioxidant Strategies in the Management of Diabetic Neuropathy

  2015cites this paper
• O EFEITO DO USO DE ANTIOXIDANTES NA PREVENÇÃO E TRATAMENTO DA NEUROPATIA DIABÉTICA NO SISTEMA NERVOSO ENTÉRICO

  2015cites this paper
• Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases.

  2015cites this paper
• Does Bosentan Protect Diabetic Brain Alterations in Rats? The Role of Endothelin‐1 in the Diabetic Brain

  2015cites this paper
• The Combined Extract of Zingiber officinale and Zea mays (Purple Color) Improves Neuropathy, Oxidative Stress, and Axon Density in Streptozotocin Induced Diabetic Rats

  2015cites this paper
• Metabolome and proteome changes with aging in Caenorhabditis elegans.

  2015cites this paper
• Rabies virus phosphoprotein interacts with mitochondrial Complex I and induces mitochondrial dysfunction and oxidative stress

  2015cites this paper
• Vascular Impairment of Epineurial Arterioles of the Sciatic Nerve: Implications for Diabetic Peripheral Neuropathy.

  2015cites this paper
• Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Oxidative stress and Antioxidant status in Ghanaians with Type 2 Diabetes Mellitus

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Evaluation of Nitric Oxide and Some Biochemical Changes in Type 2 Diabetic Patients in Hilla City

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal models of diabetic neuropathic pain.

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Mechanisms of disease: Mitochondrial dysfunction in sensory neuropathy and other complications in diabetes.

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Minocycline improves peripheral and autonomic neuropathy in type 2 diabetes: MIND study

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• Animal Models of Diabetic Neuropathic Pain

  2014cites this paper
• 12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.

  2013cites this paper
• Protective effect of the polysaccharide from Ophiopogon japonicus on streptozotocin-induced diabetic rats.

  2013cites this paper
• Aldose Reductase Inhibitors as Potential Therapeutic Drugs of Diabetic Complications

  2013cites this paper
• EVALUATION OF ANTIHYPER LIPEDEMIC ACTIVITY OF L- CITRULLINE ON DIABETES INDUCED BY HYPER LIPEDEMIC RAT MODEL

  2013cites this paper
• Contribution of mitochondria to pain in diabetic neuropathy.

  2013cites this paper
• Gender wise comparison of Blood Glucose, Blood urea and Serum Creatinine Status in Type II Diabetic and Non - Diabetic Osteomyelitis

  2013cites this paper
• Contribution of mitochondria to pain in diabetic neuropathy

  2013cites this paper
• Blood Viscosity, Lipid Profile, and Lipid Peroxidation in Type-1 Diabetic Patients with Good and Poor Glycemic Control

  2013cites this paper
• Lipid Peroxidation and Antioxidant Status in Type 2 Diabetes Mellitus in Ghana

  2013cites this paper
• Evaluation of Serum Uric Acid and Glutathione Levels in Diabetic Patients and Healthy Subjects

  2013cites this paper
• Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress.

  2013cites this paper
• Neuroprotective Effect of Quercetin on the Duodenum Enteric Nervous System of Streptozotocin-Induced Diabetic Rats

  2012cites this paper
• Neuropatia diabética : estudo dos mecanismos moleculares envolvidos com a neurotoxicidade do metilglioxal e do glicolaldeído em células diferenciadas de neuroblastoma humano SH-SY5Y

  2012cites this paper
• Linking Diabetic Complications to Sorbitol Oxidation, Oxidative Stress and Metabolic Suppression

  2012influential citation
• Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.

  2012cites this paper
• Methods for the measurement of urinary biomarkers of oxidative stressapplication to type 1 diabetes mellitus

  2012cites this paper
• Rat lung aldose reductase inhibition capacity of substituted indole hydrazide/hydrazone derivatives

  2012cites this paper
• Role of Peripheral Neuropathy in the Development of Foot Ulceration and Impaired Wound Healing in Diabetes Mellitus

  2012cites this paper